Skip to content
Artificial Intelligence Computing Leadership from NVIDIA
  • Toggle Search
  • Privacy Policy
  • Manage My Privacy
  • Legal
  • Accessibility
  • Product Security
  • Contact
Copyright © 2023 NVIDIA Corporation
  • Home
  • AI
  • Data Center
  • Driving
  • Gaming
  • Pro Graphics
  • Autonomous Machines
  • Healthcare
  • Startups
  • AI Podcast

Tag: Healthcare and Life Sciences

NVIDIA Cambridge-1 AI Supercomputer Expands Reach to Researchers via the Cloud

Mammoth Mission: How Colossal Biosciences Aims to ‘De-Extinct’ the Woolly Mammoth

Startup’s AI Slashes Paperwork for Doctors Across Africa

Meet the Omnivore: Creative Studio Aides Fight Against Sickle Cell Disease With AI-Animated Short

How AI and Crowdsourcing Can Advance mRNA Vaccine Distribution

Now Shipping: DGX H100 Systems Bring Advanced AI Capabilities to Industries Worldwide

NVIDIA Announces Partners of the Year in Europe, Middle East

NVIDIA Honors Partners in Americas Helping Industries Harness AI to Transform Business

Mitsui and NVIDIA Announce Japan’s First Generative AI Supercomputer for Pharmaceutical Industry

Load more articles

Corporate Information

  • About NVIDIA
  • Corporate Overview
  • Technologies
  • NVIDIA Research
  • Investors
  • Social Responsibility
  • NVIDIA Foundation

Get Involved

  • Forums
  • Careers
  • Developer Home
  • Join the Developer Program
  • NVIDIA Partner Network
  • NVIDIA Inception
  • Resources for Venture Capitalists
  • NVIDIA Inception GPU Ventures
  • Technical Training
  • Training for IT Professionals
  • Professional Services for Data Science

News & Events

  • Newsroom
  • NVIDIA Blog
  • NVIDIA Technical Blog
  • Webinars
  • Stay Informed
  • Events Calendar
  • NVIDIA GTC
  • NVIDIA On-Demand
Explore our regional blogs and other social networks
  • Privacy Policy
  • Manage My Privacy
  • Legal
  • Accessibility
  • Product Security
  • Contact
Copyright © 2023 NVIDIA Corporation
USA - United States

NVIDIA websites use cookies to deliver and improve the website experience. See our cookie policy for further details on how we use cookies and how to change your cookie settings.

ACCEPT
 Twitter
 Facebook
 LinkedIn
 Email